Peripheral Venous Pressure (PVP) Trial

Starting soon · Not applicable

Conditions studied: Congestive Heart Failure

In brief

The purpose of the study is to determine if there is a reduction in the length of stay and rates of rehospitalization for patients diagnosed with congestive heart failure when physicians are provided daily measurements of peripheral venous pressure versus no daily measurements of peripheral venous pressure.

Key facts

Study ID

NCT07400042

Run by

Wake Forest University Health Sciences

People needed

600

Starts

2026-08-01

Expected to finish

2031-08-01

Last updated by the study team

2026-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with minimum 3-month history of Congestive Heart Failure admitted to Aurora St. Luke's Medical Center with acute decompensation
• English speaking only

You may not qualify if…

• Patients who do not already have a peripheral IV line inserted
• Patients whose IV line cannot be transduced
• Patients with current or past vein thrombosis in the arm used to measure the pressure or with history of recurrent (>1) pulmonary embolism
• Patients with active thrombophlebitis in the arm
• Patients who have experienced a major cardiovascular event (myocardial infarction, stroke, etc.) ≤2 months prior to the admission date
• Patients who have received an implanted cardiac resynchronization device (pacemaker or ICD) ≤3 months prior to admission date
• Patients enrolled in other cardiovascular research studies.
• Patients with a clinical condition that the investigator believes may not allow the patient to complete the study, at the discretion of the investigator. Examples of conditions that may apply include severe stenotic valvular disease, isolated right ventricle failure, precapillary pulmonary hypertension, hypertrophic obstructive cardiomyopathy, implanted left ventricular assist device, history of heart transplantation, clinical diagnosis of cardiogenic shock, any left-to-right shunt
• Patients with congenital heart disease or mechanical right heart valve(s)
• Planned heart surgery and/or coronary intervention during hospitalization
• Patients expected to receive heart transplant within 6 months of admission
• IV cannula smaller than 22G
• Patients who are pregnant and/or lactating
• Patients who are unable to provide informed consent
• Patients who are intubated

Where it is running

• Aurora St. Luke's Medical Center — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.